133 results
Page 5 of 7
S-4
sfd 6touojftr
14 Jun 19
Registration of securities issued in business combination transactions
5:22pm
S-4
EX-10.40
hu9nzdqwstkd
14 Jun 19
Registration of securities issued in business combination transactions
5:22pm
8-K
EX-10.2
fdq0ozsb
14 Jun 19
Entry into a Material Definitive Agreement
8:32am
425
EX-10.2
zeuz7x5v0qv mrujm
14 Jun 19
Business combination disclosure
8:30am
8-K
EX-2.4
y7l6uwycuk31zm8gye
8 Apr 19
Histogenics and Ocugen Enter into Definitive Merger Agreement to Create Nasdaq-Listed Clinical-Stage
7:17am
8-K
EX-2.1
9vp2d sfodsitjzud6
8 Apr 19
Histogenics and Ocugen Enter into Definitive Merger Agreement to Create Nasdaq-Listed Clinical-Stage
7:17am
425
EX-2.1
y8kvozccrp4n11
8 Apr 19
Business combination disclosure
7:15am
425
EX-2.4
6vw7niss
8 Apr 19
Business combination disclosure
7:15am
8-K
EX-1.1
alxnmz2uzzse
5 Oct 18
Histogenics Corporation Announces Proposed Public Offering of
5:09pm
424B5
1snir53q ux76
5 Oct 18
Prospectus supplement for primary offering
5:05pm
424B5
0qfun 6nugoplvxo822r
5 Oct 18
Prospectus supplement for primary offering
6:05am
8-K
zn28kc ihcxomr3z
2 Oct 18
Departure of Directors or Certain Officers
4:05pm